Novel Insights into Actions of Bisphosphonates on Bone: Differences in Interactions with Hydroxyapatite

Nancollas, G.H., Tang, R., Phipps, R.J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R.G.G. +1 more·2006·Bone
DOI 10.1016/j.bone.2005.05.003

Cited by (865)

Items 401–500 of 865

  1. Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres
    Elisa Boanini, Silvia Panseri, Fabiola Arroyo, Monica Montesi, Katia Rubini, Anna Tampieri, Cristian Covarrubias, Adriana Bigi · 2016 · Materials
  2. Bisphosphonates: Synthesis, structures, properties, medical and industrial applications
    Konstantin Popov, Maxim Oshchepkov, Sergey Tkachenko, В.С. Сергиенко, Aleksandr S. Oshchepkov · 2022 · Journal of Molecular Liquids
  3. Changes in bone mineral density and bone turnover in patients on ‘drug holiday’ following bisphosphonate therapy: real‐life clinic setting
    John D. Roberts, Charlles Heldan de Moura Castro, Amelia E.B. Moore, Ignac Fogelman, G. Hampson · 2015 · Clinical Endocrinology
  4. Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis
    Steven Boonen, Richard Eastell, Guoqin Su, Peter G Mesenbrink, Felicia Cosman, Jane A. Cauley, Ian R. Reid, Frank Claessens, Dirk Vanderschueren, Kenneth W. Lyles et al. · 2012 · Journal of Bone and Mineral Research
  5. Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate
    Matthew R. Allen, John J. Turek, Roger J. Phipps, David B. Burr · 2010 · Bone
  6. Bisphosphonate therapy in CKD
    Matthew J. Damasiewicz, Thomas L. Nickolas · 2019 · Current Opinion in Nephrology & Hypertension
  7. Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice
    Motoki Isawa, Akiko Karakawa, Nobuhiro Sakai, Saki Nishina, Miku Kuritani, Masahiro Chatani, Takako Negishi‐Koga, Masashi Sato, Mitsuko Inoue, Yukie Shimada et al. · 2019 · Scientific Reports
  8. Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study
    Hiroshi Hagino, Seitaro Yoshida, Junko Hashimoto, Masayuki Matsunaga, Masato Tobinai, Toshitaka Nakamura · 2014 · Calcified Tissue International
  9. Thermodynamic dissociation constants of risedronate using spectrophotometric and potentiometric pH-titration
    Milan Meloun A, Zuzana Ferenčíková, Hana Málková, Tomáš Pekárek · 2012 · Open Chemistry
  10. Complexation of bisphosphonates with ytterbium(III): Application of phosphate and ATP detection assay based on Yb3+–pyrocatechol violet
    Ernestas Gaidamauskas, Helen Parker, B. A. Kashemirov, Alvin A. Holder, Kanokkarn Saejueng, Charles E. McKenna, Debbie C. Crans · 2009 · Journal of Inorganic Biochemistry
  11. N4-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine—New drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate)
    Herbert N. Schott, Daniel E. Goltz, Timm Cornelius Schott, Claudia Jauch, Reto Albert Schwendener · 2011 · Bioorganic & Medicinal Chemistry
  12. Quantitation of zoledronic acid in murine bone by liquid chromatography coupled with tandem mass spectrometry
    Brianne S. Raccor, Jianxun Sun, Ross F. Lawrence, Li Lei, Hai Zhang, Martha Joan Somerman, Rheem A. Totah · 2013 · Journal of Chromatography B
  13. Hollow hydroxyapatite microsphere: a promising carrier for bone tissue engineering
    Hui Yang, Huichang Gao, Yingjun Wang · 2016 · Journal of Microencapsulation
  14. Bone‐targeted delivery of TGF‐β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati–Engelmann disease
    Yunhao Qin, Shibing Tang, Gehua Zhen, Qiang Ding, Sheng Ding, Xu Cao · 2018 · Annals of the New York Academy of Sciences
  15. Predicting binding affinities of nitrogen-containing bisphosphonates on hydroxyapatite surface by molecular dynamics
    Tzu-Jen Lin · 2018 · Chemical Physics Letters
  16. Targeting geranylgeranylation reduces adrenal gland tumor burden in a murine model of prostate cancer metastasis
    Jacqueline E. Reilly, Jeffrey D. Neighbors, Huaxiang Tong, Michael D. Henry, Raymond J. Hohl · 2015 · Clinical & Experimental Metastasis
  17. Neridronic acid for the treatment of bone metabolic diseases
    Davide Gatti, Ombretta Viapiana, Luca Idolazzi, Elena Fracassi, Silvano Adami · 2009 · Expert Opinion on Drug Metabolism & Toxicology
  18. Bisphosphonate treatment and fracture repair
    Michelle Maree McDonald, Aaron Schindeler, David Graham Little · 2007 · BoneKEy-Osteovision
  19. Specificity of the zinc(ii), magnesium(ii) and calcium(ii) complexation by (pyridin-2-yl)aminomethane-1,1-diphosphonic acids and related 1,3-(thiazol-2-yl) and 1,3-(benzothiazol-2-yl) derivatives
    Ewa Matczak‐Jon, Teresa Kowalik‐Jankowska, Katarzyna Anna Ślepokura, Pawel K. Kafarski, Anna Rajewska · 2009 · Dalton Transactions
  20. Safety, pharmacokinetics, and changes in bone metabolism associated with zoledronic acid treatment in Japanese patients with primary osteoporosis
    Masataka Shiraki, Satoshi Tanaka, Hiroaki Suzuki, Satoko Ueda, Toshitaka Nakamura · 2016 · Journal of Bone and Mineral Metabolism
  21. Multifunctionalization Modulates Hydroxyapatite Surface Interaction with Bisphosphonate: Antiosteoporotic and Antioxidative Stress Materials
    Lucia Forte, Stéphanie Sarda, Paola Torricelli, Christèle Combes, Fabien Brouillet, Olivier Marsan, Francesca Salamanna, Milena Fini, Elisa Boanini, Adriana Bigi · 2019 · ACS Biomaterials Science & Engineering
  22. Non-vertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data
    Paul D. Miller · 2007 · Current Medical Research and Opinion
  23. Recent advances in bone-targeting nanoparticles for biomedical applications
    Xue Zhou, Erik Jan Cornel, Shisheng He, Jianzhong Du · 2021 · Materials Chemistry Frontiers
  24. Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy
    Xiuli Zhang, Mingjing Wei, Zhigang Zhang, Yarong Zeng, Feihong Zou, Sibo Zhang, Zhiping Wang, Fentian Chen, Hualong Xiong, Yufang Li et al. · 2024 · Journal of Controlled Release
  25. Synthesis, characterization and biological activity of hydroxyl-bisphosphonic analogs of bile acids
    Olga Bortolini, Giancarlo Fantin, Marco Fogagnolo, Stefano Rossetti, Loredana Maiuolo, Gemma Di Pompo, Sofia Avnet, Donatella Granchi · 2012 · European Journal of Medicinal Chemistry
  26. Time Course of Zoledronate Interaction with Hydroxyapatite Nanocrystals
    Elisa Boanini, Massimo Gazzano, Adriana Bigi · 2012 · The Journal of Physical Chemistry C
  27. Targeted and theranostic applications for nanotechnologies in medicine
    Saini Setua, Meena Jaggi, Murali Mohan Yallapu, Subhash C. Chauhan, Danilushkina Anna Aleksandrovna, Hojae Lee, Insung S. Choi, Rawil F. Fakhrullin, Lorenzo Degli Esposti, Anna Tampieri et al. · 2017 · Elsevier eBooks
  28. Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture
    Delphine Farlay, Sébastien Rizzo, Louis‐Georges Ste‐Marie, Laëtitia Michou, Suzanne N. Morin, Shijing Qiu, Pascale Chavassieux, Roland D Chapurlat, Sudhaker D. Rao, Jacques P. Brown et al. · 2020 · Journal of Bone and Mineral Research
  29. Nitrogen-Bisphosphonate Therapy Is Linked to Compromised Coenzyme Q10 and Vitamin E Status in Postmenopausal Women
    Shirin Kalyan, Patricia Huebbe, Tuba Esatbeyoglu, Petra Niklowitz, Hélène C F Côté, Gerald H Rimbach, Dieter Kabelitz · 2014 · The Journal of Clinical Endocrinology & Metabolism
  30. Thermodynamic study of the interaction between calcium and zoledronic acid by calorimetry
    Mohamed A. Mostefa Side Larbi, Christophe Sauzet, Philippe Piccerelle, Pierre Cau, Nicolas Lévy, Philippe Gallice, David Bergé‐Lefranc · 2016 · The Journal of Chemical Thermodynamics
  31. Probing the interaction of (001) carbonated hydroxylapatite surfaces with water: a density functional investigation
    Gianfranco Ulian, Daniele Moro, Giovanni Valdré · 2017 · Micro & Nano Letters
  32. Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget’s Disease
    Daniela Merlotti, Domenico Rendina, Riccardo Muscariello, Tommaso Picchioni, Mario Alessandri, Gianpaolo DE FILIPPO, Maria Materozzi, Simone Bianciardi, Maria Beatrice Franci, Barbara Lucani et al. · 2019 · The Journal of Clinical Endocrinology & Metabolism
  33. Local Administration of Bisphosphonate-soaked Hydroxyapatite for the Treatment of Osteonecrosis of the Femoral Head in Rabbit
    Jinhui Ma, Wanshou Guo, Zirong Li, Bailiang Wang · 2016 · Chinese Medical Journal
  34. Calcium Phosphate Bone Cements
    Erdem Şahin · 2018 · InTech eBooks
  35. Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy
    Elham Hatami, Prashanth K.B. Nagesh, Pallabita Chowdhury, Stacie Elliot, Deanna N. Shields, Subhash C. Chauhan, Meena Jaggi, Murali Mohan Yallapu · 2019 · ACS Biomaterials Science & Engineering
  36. Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment
    Yuka Kameda, Mamoru Aizawa, Taira Sato, Michiyo Honda · 2021 · International Journal of Molecular Sciences
  37. Drug-Inclusive Inorganic–Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate
    Maria Vassaki, Savvina Lazarou, Petri A. Turhanen, Duane Choquesillo‐Lazarte, Konstantinos D. Demadis · 2022 · Molecules
  38. Preparation, characterization, release kinetics, and in vitro cytotoxicity of calcium silicate cement as a risedronate delivery system
    Tianxing Gong, Zhiqin Wang, Yubiao Zhang, Changshan Sun, Quanzu Yang, Tom Troczynski, Urs O. Häfeli · 2013 · Journal of Biomedical Materials Research Part A
  39. High-frequency impedance measurement as a relevant tool for monitoring the apatitic cement setting reaction
    Christelle Despas, Verena Schnitzler, Pascal Janvier, Franck Fayon, Dominique Massiot A, Jean‐Michel Bouler, Bruno Bujoli, Alain Walcarius · 2013 · Acta Biomaterialia
  40. Ligand-Modified Aminobisphosphonate for Linking Proteins to Hydroxyapatite and Bone Surface
    Robin S. Ehrick, Marcello Capaccio, David A. Puleo, Leonidas G. Bachas · 2007 · Bioconjugate Chemistry
  41. Sol–gel derived titania coating with immobilized bisphosphonate enhances screw fixation in rat tibia
    Paula Linderbäck, Sami Areva, Per Aspenberg, Pentti Tengvall · 2010 · Journal of Biomedical Materials Research Part A
  42. Metabolische Knochenerkrankungen
    Franz Josef Jakob · 2007 · Der Internist
  43. Thermodynamic Dissociation Constants of Alendronate and Ibandronate by Regression Analysis of Potentiometric Data
    Milan Meloun A, Zuzana Ferenčíková, Lucie Netolická, Tomáš Pekárek · 2011 · Journal of Chemical & Engineering Data
  44. A new multifunctionalized material against multi-drug resistant bacteria and abnormal osteoclast activity
    Elisa Boanini, Paola Torricelli, Francesca Bonvicini, Maria Cristina Cassani, Milena Fini, Giovanna Angela Gentilomi, Adriana Bigi · 2018 · European Journal of Pharmaceutics and Biopharmaceutics
  45. Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
    Paula J. Rackoff · 2009 · Clinical Interventions in Aging
  46. Prevention and Management of Denosumab Discontinuation Rebound Fractures
    Sumeet Jain · 2024 · Endocrinology and Metabolism Clinics of North America
  47. Hybrid Au@alendronate nanoparticles as dual chemo-photothermal agent for combined cancer treatment
    Anouchka Plan Sangnier, Romain Aufaure, Laurence Motte, Claire Wilhelm, Erwann Guénin, Yoann Lalatonne · 2018 · Beilstein Journal of Nanotechnology
  48. Effect of Zoledronic Acid and Graphene Oxide on the Physical and In Vitro Properties of Injectable Bone Substitutes
    Demir-Oğuz, Öznur, Ege, Duygu · 2021 · Materials Science and Engineering: C
  49. The Global Prevalence of Vitamin D Deficiency and Insufficiency in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis
    Nor Hayati Ismail, Ali Mussa, Mutaz Jamal Al‐Khreisat, Shafini Mohamed Yusoff, Azlan Husin, Muhammad Farid Johan, Md Asiful Islam · 2023 · Nutrients
  50. Targeted Nanoparticles Based on Alendronate Polyethylene Glycol Conjugated Chitosan for the Delivery of siRNA and Curcumin for Bone Metastasized Breast Cancer Applications
    Asim Mushtaq, Li Li, Lisbeth Grøndahl, A. Anitha · 2023 · Macromolecular Bioscience
  51. Transplantable delivery systems forin situcontrolled release of bisphosphonate in orthopedic therapy
    Kai Chun Su, Xuetao Shi, Rohan Varshney, Dong‐An Wang · 2010 · Expert Opinion on Drug Delivery
  52. Pharmacotherapy of Paget's disease of bone
    Ian R. Reid · 2012 · Expert Opinion on Pharmacotherapy
  53. A sugar-based phase-transitioning delivery system for bone tissue engineering
    Tegan L. Cheng, Peter Valtchev, Ciara M. Murphy, Laurence C. Cantrill, Fariba Dehghani, DG Little, Aaron Schindeler · 2013 · European Cells and Materials
  54. Influence of treadmill training on bone structure under osteometabolic alteration in rats subjected to high‐fat diet
    Ana Paula Macedo, Roberta Carminati Shimano, Débora Taffarel Ferrari, João Paulo Mardegan Issa, Alceu Afonso Jordão, Antônio Carlos Shimano · 2016 · Scandinavian Journal of Medicine and Science in Sports
  55. Inorganic nanoparticles for theranostic use
    Lorenzo Degli Esposti, Francesca Carella, Michele Iafisco · 2018 · Elsevier eBooks
  56. From Industrial Method to the Use of Silylated P(III) Reagents for the Synthesis of Relevant Phosphonylated Molecules
    Jade Dussart‐Gautheret, Julia Deschamp, Evelyne Migianu‐Griffoni, Marc Lecouvey · 2020 · Organic Process Research & Development
  57. Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial
    Ada S. Cheung, Rudolf Hoermann, Ali Ghasemzadeh, Alistair John Tinson, Vivian Ly, Stefan V Milevski, Daryl Lim Joon, Jeffrey D. Zajac, Ego Seeman, Mathis Grossmann · 2020 · Journal of Bone and Mineral Research
  58. The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors
    Věra Hedvičáková, Radmila Žižková, Matěj Buzgo, Michala Rampichová, Eva Filová · 2021 · Biomolecules
  59. Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review.
    Paul D. Miller, Penelope Ward, T Pfister, Charlotte Leigh, Jean‐Jacques Body · 2008 · PubMed
  60. A preliminary study on the morphological and release properties of hydroxyapatite–alendronate composite materials
    Priscilla Capra, Rossella Dorati, Claudia Colonna, Giovanna Bruni, Franca Pavanetto, Ida Genta, Bice Conti · 2011 · Journal of Microencapsulation
  61. Ab initio design of drug carriers for zoledronate guest molecule using phosphonated and sulfonated calix[4]arene and calix[4]resorcinarene host molecules
    Yong-Man Jang, Chol‐Jun Yu, Jin-Song Kim, Song-Un Kim · 2017 · Journal of Materials Science
  62. The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb
    Dominika Rittler, Marcell Baranyi, Eszter Molnár, Tamás Garay, I. Jalsovszky, Imre Károly Varga, Luca Hegedüs, Clemens Aigner, József Tóvári, József Tı́már et al. · 2019 · International Journal of Molecular Sciences
  63. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts
    Anna Enjuanes, Sílvia Ruiz-Gaspà, Pilar Peris, Dolores Ozalla, Luisa Álvarez, Andrés Combalía, M. Jesús Martínez de Osaba, Ana Monegal, Albert Rodrigo Parés, Núria Guañabens · 2010 · Endocrine
  64. Pathobiology of Cancer Regimen-Related Toxicities
    Stephen T. Sonis, Dorothy M. K. Keefe · 2013 · Springer eBooks
  65. Management of osteoporosis in the aging male: Focus on zoledronic acid
    Paul K. Piper · 2009 · Clinical Interventions in Aging
  66. Interaction between a bisphosphonate, tiludronate and nanocrystalline apatite:in vitroviability and proliferation of HOP and HBMSC cells
    Patricia Pascaud-Mathieu, Reine Bareille, Chantal Bourget, Joëlle Amédée, Christian C. Rey, Stéphanie Sarda · 2012 · Biomedical Materials
  67. Ab initio investigation of the adsorption of zoledronic acid molecule on hydroxyapatite (001) surface: an atomistic insight of bone protection
    Mun-Hyok Ri, Chol‐Jun Yu, Yong-Man Jang, Song-Un Kim · 2015 · Journal of Materials Science
  68. Solubility, Activity Coefficients, and Protonation Sequence of Risedronic Acid
    Clemente Bretti, Ignacy Cukrowski, Concetta De Stefano, Gabriele Lando · 2014 · Journal of Chemical & Engineering Data
  69. Inflammatory Effects of Nitrogen-Containing Bisphosphonates (N-BPs): Modulation by Non-N-BPs
    Kazuhiro Shima, Masahiro Tsuchiya, Takefumi Oizumi, Teruko Takano‐Yamamoto, Shunji Sugawara, Yasuo Endo · 2016 · Biological and Pharmaceutical Bulletin
  70. Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates
    Yasuo Endo, Hiromi Funayama, Kouji Yamaguchi, Yuko Monma, Zhiqian Yu, Xue Deng, Takefumi Oizumi, Yosuke Shikama, Yukinori Tanaka, Satoshi Okada et al. · 2019 · YAKUGAKU ZASSHI
  71. Peri-implant and systemic effects of high-/low-affinity bisphosphonate-hydroxyapatite composite coatings in a rabbit model with peri-implant high bone turnover
    Shun Niu, Xiaorui Cao, Yan Zhang, Qingsheng Zhu, Jinyu Zhu, Ping Zhen · 2012 · BMC Musculoskeletal Disorders
  72. Effect of Clodronate on Antigenic Profile, Growth, and Differentiation of Osteoblast-Like Cells
    Francisco Javier Manzano‐Moreno, Javier Ramos‐Torrecillas, Elvira De Luna‐Bertos, Candela Reyes‐Botella, Olga García‐Martínez, Concepción Ruíz · 2016 · Journal of Oral and Maxillofacial Surgery
  73. Zoledronic Acid
    Gillian M. Keating, Lesley J. Scott · 2007 · Drugs
  74. Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis
    Meltem Zeytinoglu, Sandra Naaman, Laura T. Dickens · 2021 · Endocrinology and Metabolism Clinics of North America
  75. Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
    Seung‐Hun Lee, So‐Young Choi, Min-Su Bae, Tae‐Geon Kwon · 2021 · Maxillofacial Plastic and Reconstructive Surgery
  76. Understanding the influence of alendronate on the morphology and phase transformation of apatitic precursor nanocrystals
    Guiling Zhang, Rong Tan Huang, Zhicheng Li, Xianyan Yang, Xiaoyi Chen, Wei Xia, Xiaoliang Sun, Guojing Yang, Changyou Gao, Zhongru Gou · 2012 · Journal of Inorganic Biochemistry
  77. Effect of monthly intravenous ibandronate injections on vertebral or non-vertebral fracture risk in Japanese patients with high-risk osteoporosis in the MOVER study
    Masako Ito, Masato Tobinai, Seitaro Yoshida, Junko Hashimoto, Toshitaka Nakamura · 2015 · Journal of Bone and Mineral Metabolism
  78. Designed DNA Crystal Habit Modifiers
    Diana Zhang, Paul J. Paukstelis · 2017 · Journal of the American Chemical Society
  79. Insights into the bisphosphonate holiday: a preliminary FTIRI study
    Adele L. Boskey, Lyudmila Spevak, Yan Ma, H. Wang, Douglas C. Bauer, Dennis M. Black, Ann V. Schwartz · 2017 · Osteoporosis International
  80. Bisphosphonates and Cancer: A Relationship Beyond the Antiresorptive Effects
    Sónia Teixeira, Luís Cobra Branco, Maria Helena Fernandes, João Costa‐Rodrigues · 2019 · Mini-Reviews in Medicinal Chemistry
  81. Effects of Anti–Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice
    Megumi Ikeda, Akiko Karakawa, Hideomi Takizawa, Yuki Azetsu, Nobuhiro Sakai, Masahiro Chatani, Noriyuki Suzuki, Masamichi Takami · 2022 · Journal of Endodontics
  82. Current options for the treatment of Paget’s disease of the bone
    Daniela Merlotti, Luigi Gennari, Claudia Martini, Nuti · 2009 · Open Access Rheumatology Research and Reviews
  83. Improved small molecule drug release fromin situforming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles
    Paul D. Fisher, Pablo Palomino, Todd A. Milbrandt, J. Zach Hilt, David A. Puleo · 2014 · Journal of Biomaterials Science Polymer Edition
  84. Development and validation of a method using ultra performance liquid chromatography coupled to tandem mass spectrometry for determination of zoledronic acid concentration in human bone
    Alfredo Fabrizio Lo Faro, Raffaele Giorgetti, Francesco Paolo Busardò, Giovanni Lodi, Valeria Martini, Alberto Pispero, Marcello Iriti, Elena Maria Varoni · 2018 · Journal of Pharmaceutical and Biomedical Analysis
  85. Zoledronic acid impregnated and poly (L-lactic acid) coated 45S5 Bioglass®-based scaffolds
    Jānis Ločs, Wei Li, Marina Sokolova, Judith A. Roether, Dagnija Loča, Aldo Roberto Boccaccini · 2015 · Materials Letters
  86. A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation
    Abigail A Coffman, Jelena Basta‐Pljakic, Rosa M Guerra, Frank H. Ebetino, Mark Walden Lundy, Robert J. Majeska, Mitchell B. Schaffler · 2021 · JBMR Plus
  87. Once-yearly zoledronic acid in hip fracture prevention
    Gustavo Duque, Demontiero · 2009 · Clinical Interventions in Aging
  88. Osteonecrosis of the jaw and bisphosphonates: A comparison with white phosphorus, radium, and osteopetrosis
    Michael A. Vance · 2007 · Clinical Toxicology
  89. Bisphosphonates: Pharmacology and Use in the Treatment of Osteoporosis
    Paul D. Miller · 2008 · Elsevier eBooks
  90. The Deceiving Appearances of Osteoclasts
    Julie Glowacki · 2008 · New England Journal of Medicine
  91. The anti-osteoporotic and anti-atherogenic effects of alendronate and simvastatin in ovariectomized rats fed high fat diet: A comparative study of combination therapy versus monotherapy
    M. T. Mohamed, Sally A. Abuelezz, Suzi Sobhy Atalla, Lobna Fouad Abd El Aziz, Sonia Salib Gorge · 2017 · Biomedicine & Pharmacotherapy
  92. Inhibition of macrophage viability by bound and free bisphosphonates
    Somying Patntirapong, Pawinee Phupunporn, Daranee Vanichtantiphong, Watcharawee Thanetchaloempong · 2019 · Acta Histochemica
  93. Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
    Akira Baba, Hiroya Ojiri, Tazuko K. Goto, Koshi Ikeda, Hideomi Yamauchi, Nobuhiro Ogino, Takuji Mogami · 2019 · Japanese Dental Science Review
  94. The uptake performance and microscopic mechanism of inorganic-organic phosphorus hybrid amorphous hydroxyapatite for multiple heavy metal ions
    Yuting Chu, Mingzhu Xia, Fengyun Wang, Xin Yan, Yong Chuan Dai, Lin Dong, Yanru Zhang · 2022 · Colloids and Surfaces A Physicochemical and Engineering Aspects
  95. Determination of the Rat in Vivo Pharmacokinetic Profile of a Bone-Targeting Dual-Action Pro-Drug for Treatment of Osteoporosis
    Gang Chen, Steve Arns, Robert Norman Young · 2015 · Bioconjugate Chemistry
  96. Early tissue responses to zoledronate, locally delivered by bone screw, into a compromised cancellous bone site: a pilot study
    Joerg Arnoldi B, Antoine Alves, Philip Procter · 2014 · BMC Musculoskeletal Disorders
  97. Osteogenesis Imperfecta
    Jean‐Pierre Devogelaer, Christine Coppin · 2006 · Treatments in Endocrinology
  98. Zoledronic Acid
    Katherine Ann Lyseng-Williamson · 2008 · Drugs
  99. Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders.
    LUIGI SINIGAGLIA, MASSIMO VARENNA, Silvia Casari · 2007 · PubMed Central
  100. Chemical, radiochemical and biological studies of Sm and Ho complexes of H4dota analogues containing one methylphosphonic/phosphinic acid pendant arm
    Sara Lacerda, Fernanda Marques, Maria Paula Cabral Campello, Lurdes Gano, Vojtěch Kubíček, Petr Hermann, Isabel Santos · 2009 · Journal of Labelled Compounds and Radiopharmaceuticals